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The replication cycle of the hepatitis B virus (HBV) is still incompletely understood. In particular, the early steps of the
viral life cycle, such as absorption, penetration, uncoating, and nuclear translocation require further clarification. In this
study we performed infection experiments with HBV in primary human hepatocyte cultures. To further elucidate the possible
mechanism of virus uptake, infection experiments were performed at different pH levels, after pretreatment of viral particles
with acidic buffers and in the presence of lysosomotropic agents (chloroquine and ammonium chloride, respectively). Using
a selective PCR technique which discriminates between input virus DNA and the earliest replicative form, we could demon-
strate viral replication 36 hr after inoculation. HBV was taken up most efficiently at a pH of 7.4. Infection was still successful
after pretreatment of viral particles at low pH and was unaffected by the presence of lysosomotropic agents. In conclusion,
this suggests HBV to be a pH-independent virus. q 1997 Academic Press
Hepatitis B virus (HBV) infection is a major global Viral particles were pretreated with buffers of low pH
before infection. In the case of a pH-dependent virus thishealth problem with about 200 to 300 million chronic
HBsAg (hepatitis B surface antigen) carriers and 1 million should result in inactivation of the virus, as membrane
fusion is triggered off. In a second set of experimentsdeaths annually (1). Unfortunately, in vitro systems for
the investigation of HBV replication require well-differen- we investigated the effect of lysosomotropic agents. Ly-
sosomotropic agents, such as chloroquine or ammoniumtiated primary human hepatocytes and thus are not
readily available. Commonly used surrogate animal mod- chloride, are weak bases which enter the lysosomes
rapidly, become protonated, and increase the pH valueels are ducks and woodchucks, which have their own
within 1 to 2 min (20–23). Thus, they abolish intralysoso-hepatitis viruses (DHBV and WHBV) (e.g., 2, 3). Most
mal acidification of the virus. The use of these agents inrecently, successful infections of tree shrews (Tupaia
DHBV infection systems has resulted in conflicting re-belangeri) with HBV were carried out by Walter et al. (4)
ports. Offensperger et al. (20) demonstrated reduced in-which might present a new promising animal system. We
fectivity of DHBV after treatment with chloroquine or am-have established an in vitro system for the propagation of
monium chloride. Rigg and Schaller (21) showed undis-HBV in primary human liver cells (5) which here was
turbed infection in the presence of ammonium chlorideused to study the pH dependence of HBV infection.
and monensin. Ko¨ck et al. (22) also found that lysosomo-Enveloped viruses enter the host cell either by direct
tropic agents have no effect, suggesting that this virusfusion with the cell membrane or by receptor-mediated
is pH-independent.endocytosis (6 – 12). These two different forms of virus –
In our study we used primary human liver cells pre-host cell interaction can be distinguished by their pH
pared from healthy tissue obtained during hepatic sur-requirements. Viruses with dependence on low pH such
gery as previously described (5). The study was approvedas influenza (13 – 15) and Semliki Forest virus (16) show
by the Ethics Committee of the Medizinische Gesamtfa-sharp pH profiles regarding fusion with membranes of
kulta¨t der Universita¨t Heidelberg.acidic endosomes; pH-independent viruses like herpes
To demonstrate successful viral infection we used afuse with the plasma membrane and possibly also with
selective PCR technique which discriminates betweenthe endosomes (17 – 19). In order to test the pH require-
total viral HBV DNA and double-stranded, repaired intra-ments of HBV, a set of different experiments was per-
cellular HBV DNA (CCC DNA). This technique has beenformed.
previously introduced for DHBV (24) and was modified
for HBV. PCR was performed with two different primer
pairs which both bind to viral DNA, but only one of them1 To whom reprint requests should be addressed. Fax: 0049-6221-
564922. selectively amplifies CCC DNA (24). As shown in Fig. 1
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FIG. 3. PH optimum of viral uptake. Inoculation was performed for
1 hr in Earle’s salt solution (Serva, Heidelberg, Germany) containing
supplements identical to those in the culture medium. It was buffered
to pH values 6.4 and 6.8 with piperazine-N,N*-bis(2-ethanesulfonic acid)
and to pH values 7.6 and 7.2 with N-2-hydroxyethyl piperazine-N*-2-
ethanesulfonic acid. Cells were harvested after 48 hr and analyzed
for total and replicative viral CCC DNA. Experiments were performed
independently three times. V, virus control; P, plasmid control.
FIG. 1. Differential amplification of virus- or plasmid-derived HBV
strating the potential of this method to differentiate be-DNA. To differentiate between encapsulated viral DNA (RC DNA) and
complete double-stranded forms (CCC DNA/plasmid DNA) two pairs tween the two DNA species. Since denaturation of CCC
of primers were used for amplification of serial dilutions of serum- DNA depends on strand scission we performed a control
derived virus (after digestion with 0.1 mg/ml proteinase K at 377 for 5 PCR after enzymatic digest of plasmid DNA with EcoRIhr) or of plasmid-derived HBV DNA (pd4aI, Ref. 5): HBV 1966/, 5*TCG
(Fig. 1, bottom). This resulted in an insignificant increaseCAT TTG TTC AGT GGT TCG TAG GGC 3* and HBV 28300, 5*CCG
in sensitivity, proving that CCC DNA is efficiently dena-GCA GAT GAG AAG GCA CAG ACG 3* for the amplification of total
viral DNA; HBV 2537/, 5*CCT CTG CCG ATC CAT GCG GAA 3* and tured during the PCR reaction.
HBV 4700, 5*CTG CGA GGC GAG GGA GTT CTT CTT 3* for the prefer- By means of this technique successful infection was
ential amplification of double-stranded viral CCC DNA (24). A PCR shown 36 hr postinoculation by the appearance of CCCsample of 100 ml contained 10 ml 101 Taq buffer, 2.5 U Taq polymerase
DNA (Fig. 2a), clearly earlier than can be achieved by(Stratagene, Heidelberg, Germany), nucleotide mix of 20 nM each and
conventional Southern blotting (5). Due to the high sen-2 ng of each primer. Distilled, sterile water was added up to 90 ml.
Amplification was performed using a thermal cycler C100 (Perkin– sitivity of this technique successful infection as demon-
Elmer, Norwalk, CT): one denaturation step of 947 for 3 min was fol- strated by the appearance of CCC DNA 48 hr after
lowed by 30 cycles of 947 for 1 min, 587 for 1 min, and 727 for 2 min. 10 inoculation could be achieved down to a multiplicity of
ml of the PCR products was separated on 1% agarose and transferred to
infection (m.o.i.) of 5 1 105 to 1 1 105 virions per assaya nylon membrane (Pall, Langen, Germany) by a pressure-blotting sys-
(Fig. 2b).tem (Stratagene). Southern blotting was performed with the DIG system
(Boehringer, Mannheim, Germany) according to the protocol of the This system was used to further study pH dependence
manufacturer, using CSPD (Tropix, MA) as substrate and random-la- of HBV entry and replication in host cells. To define the
beled plasmid pd4aI as probe. The X-ray film was exposed for about pH optimum of viral uptake infection, experiments were30 min.
performed at different pH and analyzed for the appear-
ance of CCC DNA 48 hr after infection. Strongest signals
for CCC DNA were obtained at physiological pH (Fig.(top) both primer pairs amplify plasmid-derived continous
3). Acidic pH progressively prevented the infection ofHBV DNA (pd4aI; Ref. 5) at comparable levels. In contrast,
hepatocytes with HBV, as demonstrated by the loss ofdiscontinuous input viral DNA was detected with about
the CCC DNA signal with increased acidification of the1000-fold lower efficiency by the primer pair for CCC
culture medium.DNA than by the primer pair for total viral DNA, demon-
FIG. 2. Detection of total and replicative viral CCC DNA. (a) Cells were prepared and cultured as previously described (5). Infection was performed
by incubation with 100 ml HBV-containing serum (about 1 1 108 viral particles/ml) for 1 hr in 12-well dishes. Cells were harvested at indicated
times and digested with lysis buffer (50 mM KCl, 10 mM Tris, 0.45% Tween 20, 0.45% Nonidet-P40, 0.1 mg/ml proteinase K) at 567 for 2 hr. Proteinase
K was inactivated at 957 for 10 min (24). 10 ml was used for PCR as described for Fig. 1. Similar results were obtained in several independent
infection experiments. To control differential amplification of RC vs CCC DNA serum-derived viral DNA (V) and plasmid DNA (P) were used as
controls. (b) Different m.o.i.s were used for infection experiments as indicated and a PCR reaction was performed 48 hr after inoculation.
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use of long-term treatment (2 weeks) with lysosomotropic
agents which might significantly affect the functional in-
tegrity of hepatocytes.
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